|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7,550.00 JPY | -0.21% |
|
+1.34% | -8.41% |
| 06-15 | Goldman Sachs Upgrades Chugai Pharmaceutical to Buy from Neutral; Price Target is 8,950 Yen | MT |
| 05-26 | Major Asian Stock Markets Fall Amid Renewed Middle East Tensions | MT |
| Market Cap | 12,426B 76.95B 67.14B 62.15B 58.3B 109B 7,264B 110B 732B 286B 3,576B 289B 283B | P/E 2026 * |
24.3x | P/E 2027 * | 20.9x |
|---|---|---|---|---|---|
| Enterprise Value | 11,503B 71.24B 62.15B 57.54B 53.97B 101B 6,724B 102B 678B 264B 3,310B 268B 262B | EV / Sales 2026 * |
8.29x | EV / Sales 2027 * | 7.33x |
| Free-Float |
38.12% | Yield 2026 * |
1.81% | Yield 2027 * | 2.08% |
Last Transcript: Chugai Pharmaceutical Co., Ltd.
| 1 day | -0.21% | ||
| 1 week | +1.34% | ||
| Current month | -4.33% | ||
| 1 month | -4.42% | ||
| 3 months | -12.72% | ||
| 6 months | -8.94% | ||
| Current year | -8.41% |
| 1 week | 7,376 |  | 7,719 |
| 1 month | 7,270 | | 8,215 |
| Current year | 7,270 | | 10,700 |
| 1 year | 5,942 | | 10,700 |
| 3 years | 3,767 | | 10,700 |
| 5 years | 3,191 | | 10,700 |
| 10 years | 1,003.33 | | 10,700 |
| Manager | Title | Age | Since |
|---|---|---|---|
Osamu Okuda
CEO | Chief Executive Officer | 63 | 2020-12-31 |
Iwaaki Taniguchi
DFI | Director of Finance/CFO | - | 2024-03-27 |
Hisafumi Okabe
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Masayuki Oku
BRD | Director/Board Member | 81 | 2015-02-28 |
Motoo Ueno
BRD | Director/Board Member | 68 | 1993-02-28 |
James Sabry
BRD | Director/Board Member | 67 | 2019-02-28 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.21% | +1.34% | +5.02% | +75.58% | 77.05B | |
| -1.21% | -3.04% | +44.03% | +143.07% | 980B | |
| -2.48% | -5.18% | +52.47% | +39.15% | 550B | |
| -2.14% | -4.94% | +16.83% | +57.08% | 382B | |
| +0.25% | -3.09% | +23.33% | +16.04% | 316B | |
| +0.61% | -1.69% | +27.35% | +13.73% | 272B | |
| +0.22% | -3.10% | +24.67% | +30.49% | 268B | |
| +4.59% | +1.98% | -38.43% | -46.26% | 199B | |
| -1.19% | -4.95% | +16.68% | +47.69% | 182B | |
| -1.35% | -1.46% | +14.06% | +59.26% | 154B | |
| Average | -0.29% | -2.58% | +18.60% | +43.58% | 337.94B | |
| Weighted average by Cap. | -0.77% | -3.56% | +28.93% | +63.59% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1,387B 8.59B 7.49B 6.94B 6.51B 12.17B 811B 12.26B 81.71B 31.87B 399B 32.26B 31.58B | 1,535B 9.51B 8.29B 7.68B 7.2B 13.47B 897B 13.57B 90.43B 35.28B 442B 35.71B 34.95B |
| Net income | 511B 3.16B 2.76B 2.55B 2.4B 4.48B 299B 4.52B 30.08B 11.73B 147B 11.88B 11.63B | 593B 3.67B 3.2B 2.97B 2.78B 5.21B 347B 5.25B 34.94B 13.63B 171B 13.8B 13.5B |
| Net Debt | -923B -5.71B -4.98B -4.61B -4.33B -8.1B -539B -8.16B -54.35B -21.2B -266B -21.46B -21B | -1,166B -7.22B -6.3B -5.83B -5.47B -10.23B -681B -10.31B -68.67B -26.79B -335B -27.12B -26.54B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-19 | 7,550.00 ¥ | -0.21% | 3,697,700 |
| 26-06-18 | 7,566.00 ¥ | -1.10% | 1,954,000 |
| 26-06-17 | 7,650.00 ¥ | +1.69% | 1,745,000 |
| 26-06-16 | 7,523.00 ¥ | +1.28% | 2,083,200 |
| 26-06-15 | 7,428.00 ¥ | -0.30% | 1,824,000 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4519 Stock
Select your edition
All financial news and data tailored to specific country editions
